Results 131 to 140 of about 71,439 (210)

GRIP-Lung: Generative Model of Response to Drug-Induced Perturbation in Lung Cancer. [PDF]

Int J Mol Sci
Fu Z, Li Y, Du Z, Zhang D, Liu L, Jin Q, Chen X, Xie H.   +7 more
europepmc   +1 more source

Epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of non-small cell lung cancer in the past 30 years (1997-2026). [PDF]

Chin Med J (Engl)
Xie Z, Chen X, Gao R, Yang M, Han X, Sun Y, Shi Y.   +6 more
europepmc   +1 more source

Combinatorial inhibition of IGF2BP3-regulated receptor tyrosine kinases offers a new therapeutic strategy for triple-negative breast cancer. [PDF]

J Exp Clin Cancer Res
Wang ZW, Zhang X, Wang YX, Cai MY, Chen J, Sang MY, Yang HY, Shi L, Wei JF, Ding Q.   +9 more
europepmc   +1 more source

HIF-1α siRNA Enhances the Efficacy of Erlotinib in Non-small Cell Lung Cancer: A Novel Strategy to Reverse Hypoxia-Induced Drug Resistance. [PDF]

Drugs R D
Jiang H, Cai S, Zhang X, Chen S, Yue C, Yin W, Hu Y.   +6 more
europepmc   +1 more source

Safety Profile and Tumor Response of EGFR-TKIs in Clinical Practice: A Real-World Study in Thailand. [PDF]

J Clin Med
Jainan P, Pongsathabordee C, Sadabpod K, Junkrut T, Jerasirichot T, Phetchuensakun O, Paiboonvong T, Srithonrat S.   +7 more
europepmc   +1 more source

Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy. [PDF]

PLoS One
Ibraheem W, Alsheikh F, Alzain AA, Bhongade BA, Ejaz L, Baig H, Robinson RC, El-Tanani M.   +7 more
europepmc   +1 more source

Case Report: A patient with metastatic fumarate hydratase-deficient renal cell carcinoma associated with leiomyomatosis: real-world clinical insights on systemic therapy and liver-directed SBRT. [PDF]

Front Oncol
Chong HJ, Murray A, Chong KJ.
europepmc   +1 more source

Design, synthesis and antiproliferative, apoptotic, and immunomodulatory properties of new heteroaryl pyridine-linked 1,2,4-oxadiazoles as prospective dual EGFR/BRAF^V600E inhibitors. [PDF]

RSC Adv
Gomaa HAM, Shaker ME, Alzarea SI, Alatwi E, Mohamed FAM, Abdullah Alzahrani AY, Alyami BA, Bräse S, Rabea SM, Youssif BGM.   +9 more
europepmc   +1 more source

Hepatotoxicity and efficacy associated with first- and new-generation EGFR-TKIs in patients with NSCLC: a systematic review and meta-analysis. [PDF]

BMC Cancer
Wang Z, Meng J, Liu G, Wang Y, Li Y, Zhang C, Liu Y, Sun G.   +7 more
europepmc   +1 more source

An EGFR co-amplified lncRNA HELDR promotes glioblastoma malignancy through KAT7-driven gene programs. [PDF]

Nat Cell Biol
Yu X, Song X, Schäfer RA, Meng Q, Tiek D, Wu R, He Q, Walker M, Cao Q, Yang R, Hu B, Cheng SY.   +11 more
europepmc   +1 more source